Search hospitals > Ohio > Cincinnati
Cincinnati Children's Hospital Medical Center
Claim this profileCincinnati, Ohio 45229
Global Leader in Tumors
Global Leader in Leukemia
Conducts research for Syndrome
Conducts research for Brain Tumor
Conducts research for Neuroblastoma
1909 reported clinical trials
143 medical researchers
Summary
Cincinnati Children's Hospital Medical Center is a medical facility located in Cincinnati, Ohio. This center is recognized for care of Tumors, Leukemia, Syndrome, Brain Tumor, Neuroblastoma and other specialties. Cincinnati Children's Hospital Medical Center is involved with conducting 1,909 clinical trials across 1,613 conditions. There are 143 research doctors associated with this hospital, such as Brian Weiss, MD, Joseph G. Pressey, Erin H Breese, MD, PhD, and Peter de Blank, MD.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Leukemia
Global LeaderHLA-A negative
HLA-A positive
HLA positive
Top PIs
Brian Weiss, MDCincinnati Children's Hospital Medical Center2 years of reported clinical research
Expert in Neuroblastoma
Studies Tumors
27 reported clinical trials
48 drugs studied
Joseph G. PresseyCincinnati Children's Hospital Medical Center8 years of reported clinical research
Studies Tumors
Studies Recurrence
21 reported clinical trials
69 drugs studied
Erin H Breese, MD, PhDCincinnati Children's Hospital Medical Center7 years of reported clinical research
Expert in Lymphoma
Expert in Recurrence
20 reported clinical trials
48 drugs studied
Peter de Blank, MDCincinnati Children's Hospital Medical Center4 years of reported clinical research
Expert in Brain Tumor
Studies Astrocytoma
20 reported clinical trials
29 drugs studied
Clinical Trials running at Cincinnati Children's Hospital Medical Center
Astrocytoma
Attention Deficit Hyperactivity Disorder (ADHD)
Chronic Kidney Disease
Neurofibromatosis
Kidney Disease
Polycystic Kidney Disease
Low Grade Glioma
Ovarian Tumors
Brain Tumor
Cystic Fibrosis
Dabrafenib + Trametinib
for Brain Tumors
This trial is studying the effects of two cancer medications, dabrafenib and trametinib, in children. These drugs work by stopping signals that make cancer cells grow. Dabrafenib and trametinib have shown benefits in various BRAF-mutant tumors, including melanoma, lung cancer, and thyroid cancer. The goal is to see how these treatments affect children over time.
Recruiting3 awards Phase 47 criteria
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cincinnati Children's Hospital Medical Center?
Cincinnati Children's Hospital Medical Center is a medical facility located in Cincinnati, Ohio. This center is recognized for care of Tumors, Leukemia, Syndrome, Brain Tumor, Neuroblastoma and other specialties. Cincinnati Children's Hospital Medical Center is involved with conducting 1,909 clinical trials across 1,613 conditions. There are 143 research doctors associated with this hospital, such as Brian Weiss, MD, Joseph G. Pressey, Erin H Breese, MD, PhD, and Peter de Blank, MD.
Where is Cincinnati Children's Hospital Medical Center located?
**Directions to Cincinnati Children's Hospital Medical Center:**
- **Address:** 3333 Burnet Ave, Cincinnati, OH 45229.
- **Directions:** Take I-71 S to exit 3A for Reading Rd. Turn left onto Reading Rd, which continues onto Burnet Ave. The hospital will be on your right.
Who should I call to ask about financial aid or insurance network?
**Cincinnati Children's Hospital Medical Center Financial and Insurance Assistance Contacts**
- **Financial Assistance**: Email PFC@cchmc.org or call 513-803-6577, Monday – Friday, 7:30 a.m. to 5:00 p.m.
- **Financial Advocates**: Contact at 513-636-4427 or email FFA@cchmc.org for financial resource assistance.
- **Billing**: For billing inquiries, visit the Online Business Office or call 1-877-430-8495 option #1 or 513-636-4427.
- **Insurance**: For insurance questions, call 513-636-4200 (local) or 1-800-344-2462 (toll free).
- **Patient Financial Services**: Write to CCHMC Patient Financial Services, 3333 Burnet Avenue, MLC 5011, Cincinnati, OH 45229-3026 for additional financial assistance.
What insurance does Cincinnati Children's Hospital Medical Center accept?
Cincinnati Children's Hospital Medical Center accepts most insurance plans, including Medicaid, Molina, and Paramount. They offer resources for families with special healthcare needs and those under or uninsured, assisting with health insurance issues. For individual coverage details, it's advised to contact the insurance carrier directly.
What awards or recognition has Cincinnati Children's Hospital Medical Center received?
Cincinnati Children's Hospital Medical Center is renowned for its exceptional research and care, earning the #1 spot on the 2023-24 U.S. News & World Report list of Best Children's Hospitals. It also ranks second among all children's hospitals and medical school pediatric departments in terms of research funding from the National Institutes of Health (NIH).